Relapsing fever borreliosis in Eurasia—forgotten, but certainly not gone!  by Assous, M.V. & Wilamowski, A.
Relapsing fever borreliosis in Eurasia—forgotten, but certainly not gone!
M. V. Assous1,2 and A. Wilamowski3
1) Laboratory of Microbiology and Immunology, Shaare Zedek Medical Center, 2) Department of Clinical Microbiology, Hadassah Medical School,
Kiryat Ein Kerem and 3) Entomology Laboratory, Ministry of Health, Jerusalem, Israel
Abstract
Tick-borne relapsing fever (TBRF) has been reported in Eurasia and attributed mainly to Borrelia persica, although other entities have
also been described. Ornithodoros tholozani is the most important tick vector, found in India and Kashmir, the southern countries of
the former USSR, Iran, Iraq, Syria, Jordan, Turkey, Israel, Egypt, and Cyprus. It inhabits caves, ruins, and burrows of rodents and small
mammals. In the northern countries, O. tholozani also lives in houses and cowsheds. In Israel, 30–60% of caves were found to be
infested. PCR studies of Borrelia infection of O. tholozani ticks collected in caves showed very variable rates, ranging from less than 2%
to 40%. The number of human cases reported varies among countries, from eight cases per year in Israel to 72 cases per year in
Iran. The incubation period is 5–9 days. The fever attacks last from several hours to 4 days, and are accompanied by chills, headache,
nausea and vomiting, sweating, abdominal pain, arthralgia, and cough; complications are rare. Other described Borrelia species are
Borrelia caucasica, Borrelia latyschewii, Borrelia microtii, and Borrelia baltazardi. The classic taxonomy based on the co-speciation concept
is very complex and very confusing. For this reason, 16S rRNA and ﬂaB genes were used for taxonomic clariﬁcation. Sequencing of
Israeli TBRF ﬂaB genes, from human and tick samples, has demonstrated a third cluster corresponding to the Eurasia strains, in
addition to both New World and Old World clusters. Thin and thick blood smears remain the most frequently used methods for
laboratory diagnosis, with a sensitivity of 80%. PCR-based diagnosis is the most sensitive method, and has the advantage of allowing
species identiﬁcation.
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Introduction
In Eurasia, tick-borne relapsing fever (TBRF) was ﬁrst
described by Dschunkowsky [1] in the Ardabil region of Iran,
and for this reason it was called Borrelia persica [2]. However,
in the same area, as early as 1882, Tholozan published the
ﬁrst clinical description of a case of TBRF, which he called
‘ﬁe`vre re´currente asiatique’, and which was transmitted to
humans by an Ornithodoros tick [3]. In the following decades,
cases of relapsing fever (RF) were reported all over the Mid-
dle East region and were attributed mainly to B. persica, but
other bacteria were also described [4–10]. Despite this, little
was known about the bacterium itself or its natural reser-
voirs. In the years 2002–2008, several studies were published
in Israel that involved gathering data about the vector, the
disease, and the bacterium, demonstrating that this long-
standing disease is still present [11–15].
The Vectors and The Reservoir
Ornithodoros tholozani
The distribution area of O. tholozani overlaps the distribution
area of clinical RF cases caused by B. persica. The tick is
widely distributed throughout India and Kashmir, the south-
ern countries of the former USSR (Kazakstan, Kyrgizia, Taji-
kistan, Turkmenistan, and Uzbekistan), Iran, Iraq, Syria,
Jordan, Turkey, Israel, and Egypt [16]. Goubau [17] also
reported this tick in Cyprus, and noted the possibility that
RF might exist in Afghanistan, Pakistan, and Libya.
The biology of O. tholozani was studied in Israel by Lidror
[18] and Avivi et al. [19,20]. It inhabits areas such as caves,
ancient ruins, and archaeological sites, where it digs itself
into the soil up to a depth of 1 m, or hides in wall crevices
where suitable microclimatic conditions exist, i.e. very high
humidity of 70–80%, relatively low temperature (17–25C),
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and dim light. In the northern countries of its distribution
area—Iran, Kashmir, Afghanistan, and the southern countries
of the former USSR—O. tholozani also lives in houses and
cowsheds, where suitable conditions are found [21,22].
O. tholozani feeds on any warm-blooded host that comes
into its habitat range. It can detect and attach to its host
within as little as 10–20 min [5,23]. According to Goubau
[17], the ticks are capable of locating their host from a dis-
tance of almost 30 m. The tick sucks blood from the host for
20–30 min, and then returns to its hiding place. Consequently,
the population level and length of the life cycle are dependent
upon the presence of a host for blood meals. If hosts are plen-
tiful, the whole life cycle lasts between 7 and 12 months. With
only sporadic host availability, ticks at all stages can survive
for 5–10 years or more without feeding [24].
In contrast to other ticks, Ornithodoros does not migrate
from its original habitat. In rare cases, ticks may be trans-
ferred to another biotope by the host while the tick is
attached for feeding. In Israel, it was found that between
30% and 60% of caves were infested with O. tholozani, but
infestation levels decrease in hotter and dryer areas, with no
infestation in desert environments in southern Israel [20].
O. tholozani ticks collected using CO2 traps (Fig. 1) have
been investigated using PCR to determine their infection
rates [15]. The number of ticks collected ranged from sev-
eral to thousands (Fig. 2). Infection rates were very variable,
ranging from less than 2% to 40%.
Other Ornithodoros vectors
Babudieri [25] reported that the tick Ornithodoros coniceps, a
known parasite of chickens that often resides in stone
chicken houses, was also a vector of a Borrelia spp., causing
TBRF cases in the town of Nablus. Similarly, in Iran, Ornithod-
oros lahorensis was found to be infected with Borrelia spp.
[22]. In Azerbijan, Ornithodoros verrucosus is a vector of
Borrelia caucasica, which causes a very severe TBRF, and in
Iran and the countries of Central Asia of the former USSR,
Ornithodoros tartakowskyi is the vector of Borrelia latyshewii,
which causes a very mild RF without apparent clinical
relapses [17].
The reservoir
O. tholozani mainly feeds on rodents and small mammals.
According to Parola and Raoult [16], these animals consti-
tute the natural reservoir. In Israel, no rodents or other
mammals have been found to be infected with Borrelia, with
the exception of a single badger [26]. It is known that tran-
sovarial transmission of the bacteria occurs from the adult
to the offspring via the eggs [27]. Therefore, the tick may
serve as both reservoir and vector. It is known that O. tholo-
zani can remain infected for many years, even if does not
feed [17]. In Jordan, a bat, Pipistrellus kuhli, was found to be
infected with Borrelia that was morphologically identical to
the Borrelia found in TBRF patients [28]. The fact that in
Central Asia bats are reservoirs of the causative agent of
TBRF transferred by O. tholozani [29] indicates the possibility
that bats may be the reservoir of this Borrelia species in
Jordan [30].
Epidemiology
In Israel, 230 cases of TBRF were recorded in the civilian
population between the years 1980 and 2007 [11], an aver-
age of eight cases per year (range: 0–16). A great number of
cases, averaging 6.4 per 100 000, were also found among
Israeli soldiers between 1971 and 2002 [12]. As far as the
civilian population is concerned, 86% of the infestation foci
were caves and 5% were ruins, and individual cases wereFIG. 1. CO2 trap (used with dry ice) for tick collection.
FIG. 2. Thousands of Ornithodoros ticks collected using a dry ice
trap.
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recorded in areas of rocks and beside animal burrows. There
have also been cases where persons who sat or lay on the
ground at a distance of several metres from an infestation
focus have been infected with Borrelia spp.
The number of TBRF cases in Israel decreased from
97 cases in 1947, in a population of 0.6 million inhabitants, to
0–8 cases per year since 1992 in a population of 6.57 million.
The reasons for this decrease are: (i) awareness and educa-
tion of the public about the danger of entering caves and the
need to take preventive measures; (ii) preventive control
measures carried out in caves and at other tourist sites; and
(iii) expansion of urban areas with concomitant destruction of
cave sites that were natural foci of TBRF infestation.
Among the people infected, 92% were hikers, and only
7.5% were professionals who entered infested habitats during
the course of their work. The latter normally take the nec-
essary precautions. Fifty per cent of the total cases were
youths, up to the age of 18 years, most being infected during
their summer vacation. In Israel, O. tholozani remains active
during winter; consequently, infection is possible throughout
the year.
In hot and dry countries such as Jordan, the disease charac-
teristics are very similar to those described in Israel. The
number of patients is directly related to the number of per-
sons entering caves without taking any preventive measures.
In Jordan, between 1959 and 1969, there were 723 cases of
TBRF (72 cases annually), of which four were fatal [30]. This
number includes cases recorded from the West Bank of the
River Jordan, which at that time was in the Kingdom of Jordan
(and which is presently under the Palestinian Authority).
These ﬁgures show that, also in Jordan, there has been a sig-
niﬁcant decrease in the number of cases from the 230 cases
recorded annually in 1951–1954 [25]. In Jordan, it is also
probable that the disease can be contracted throughout the
year. TBRF patients are again mainly young people, such as
herdsmen, who are exposed to the ticks when entering caves.
In countries such as Iran and Uzbekistan, where O. tholozani
infests both houses and cowsheds, people of all ages may be
exposed to the disease [21,22,30]. The main endemic area of
TBRF cases caused by B. persica in Iran is Ardabil, located in
the northwest of that country. Between 1998 and 2001, 391
cases were recorded, and 83.4% of the patients were children
or people not working away from home. More than 84%
were from villages; 70% of the patients lived in old buildings,
64% of which also housed sheep or cattle [22].
Clinical Features
In 1919, Nicholson described a cluster of 14 cases of TBRF
that occurred in British troops [4]. He performed a very
nice epidemiological study in which he clearly distinguished
between this tick-borne RF and the classic louse-borne fever.
Interestingly, the Palestine war in 1918 began with an epi-
demic wave of several hundred cases of louse-borne RF that
he described in the beginning of his paper.
This cluster of TBRF was closely related to a common
location (Ras-el-Ain Castle), where all of the soldiers were
at the same bivouac. Clinically, the TBRF attacks were similar
to the louse-borne ones, but Nicholson pointed out that the
accompanying symptoms of this new TBRF were much less
severe. The borreliae seen in the patients’ blood were indis-
tinguishable from louse-borne borreliae. However, Nicholson
mistakenly identiﬁed the tick vector as Argas persicus.
The complete description of the natural history of the dis-
ease, based on 45 serial cases, was published by Adler in
1937 [5]. The incubation period was between 5 and 9 days
(median: 7–8 days). The number of tick bites (Fig. 3)
FIG. 3. Lesions caused by Ornithodoros tholozani bites.
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appeared to correlate with a shorter period of incubation.
The number of fever attacks ranged from 1 to 14, but 70%
of cases had less than four attacks. Their duration varied
from several hours to 4 days, and the attacks were often
accompanied by intense eye pain, headache, nausea, vomiting,
dyspnea, and joint pains. A slight enlargement of the spleen
and liver and a hardly noticeable icterus occurred in one
case. Complications were rare (three cases), and consisted
of neurological and ophthalmological signs.
A report on TBRF in Jordan [25] described clinical aspects
that do not differ signiﬁcantly from those described by Adler.
Arshi [22] reported cases from Iran that differed, being
transmitted from a domestic environment. The inhabitants
there lived in dwellings with earth ﬂoors, often in close con-
tact with domestic animals. This fact certainly explains the
very high incidence of the disease (average of 72 cases per
year).
In this study, all symptoms were statistically quantiﬁed,
including a comparison among children, residents, and visi-
tors. Fever, chills, headache, nausea and vomiting, sweating,
abdominal pain, arthralgia and cough were found at similar
frequencies in these three groups. Interestingly, photophobia,
epistaxis, jaundice, haematuria and petichiae were found in
the resident group (19.1%, 9.6%, 4.5%, 4%, and 2.9%, respec-
tively) but not in the visitor group. In conclusion, all the
above clinical features caused by B. persica seem very similar.
There is very little information on the other species of
Borrelia reported to occur in Eurasia. According to Rodhain
[10], B. latyschevii is the causative agent of a very benign bor-
reliosis in humans, with fever lasting 1 day, or otherwise an
occult sickness. Although the bacteraemia is undetectable,
the blood can infect a newborn rabbit [10]. In contrast, the
infection in humans caused by B. caucasica is severe, causing
10–15 relapses in the space of 3 months. Finally, Borrelia
baltazardii [31] was isolated from the blood of a patient
suffering from thrombocytopenic purpura.
Taxonomy
TBRF caused by Borrelia species is generally called ‘Asian or
Asiatic TBRF’ [17,32]. It seems that the geographical distri-
bution of the borelliae more or less corresponds to Eur-
asia. The most important is B. persica [1], which causes the
large majority of human cases and has the widest distribu-
tion. Two other species are regularly cited, i.e. B. caucasica
and B. latyschewii [2,27]. Borrelia microtii is considered to
belong to the Crocidurae group, and was described in 1946
[10]. Another species, described 30 years ago, is B. balta-
zardi [31].
In 1976, Rodhain summarized [10] the then current
knowledge of TBRF-causing species from all over the world.
This review, written in French, was translated into English
(Brooks Air Force Base, Texas) and is available at http://
lrs.afpmb.org/rlgn_app/ar_login/guest/guest. Rodhain presents
a very precise description of a great number of ‘binomes’
comprising each species of tick and its associated RF-causing
Borrelia. This association is deﬁned as the ‘co-speciation con-
cept’, and is the basis of RF Borrelia taxonomy. In this
approach, the only characters that can be used in taxonomy
were: (i) the vector species; (ii) the geographical location;
(iii) the spectrum of laboratory animal pathogenicity; and (iv)
the experimental transmission of Borrelia by different arthro-
pods. This approach contributes to creating great complexity
[17], because these characters do not allow differentiation
between two Borrelia species with sufﬁciently great precision.
To simplify this complexity, Rodhain regrouped the numer-
ous binomes into several great complexes (Table 1). On the
basis of electron microscopic ﬁndings, ultrastructural differ-
ences, and experimental pathogenicity, Karimi et al. [31]
described the new species B. bartarzardi.
The fastidious culture requirements of TBRF-causing spe-
cies have prevented the use of DNA-relatedness studies,
which are otherwise widely used for taxonomic purposes.
For these reasons, and to avoid selection bias, PCR ampliﬁ-
cation combined with gene sequencing offers great promise
for taxonomic studies. The ﬁrst study that included one Eur-
asian TBRF species (B. persica) was conducted by Narti et al.,
using 16S rRNA gene sequencing [33], and compared 20
strains of RF Borrelia. The nucleotide similarity within each
species was 100%. The similarity between B. persica and
other species was 98.4–98.7%. This was not sufﬁcient to
place it in a separate cluster. Narti et al. concluded that the
status of B. persica is uncertain. The ﬂagellin gene (ﬂaB) was
subsequently used for taxonomic studies of borreliae causing
RF and Lyme borreliosis [34]. It has also separated into two
clusters, one for RF in the New World and one in the Old
TABLE 1. Pathogenicity for experimental animals of
Eurasian TBRF-causing Borreliae
Borrelia
species
Experimental animal
Guinea-pig
adult
Rabbit
newborn
Rat
newborn
Mice
adult
B. persica +++ +++ ) +
B. microtti + ++++ ++++ ++
B. latyschevi ) +++ ++ +
B. bartalzardi ) + + +/)
B. causica ) ++ ) )
Adapted from [31] and [32]
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World, but, regrettably, B. persica strains were not included
in this study. A more recent study [15] on Israeli TBRF spec-
imens demonstrated a third cluster corresponding to the
Eurasia strains (Fig. 4). The ﬂaB gene sequences from human
and tick samples were 98–100% identical. All of the trans-
lated amplicon sequences showed a speciﬁc signature, in that
they had a seven amino acid gap at position 216, when
compared with previously described ﬂaB genes of TBRF
borreliae. In addition, the amino acid sequences of FlaB of
local TBRF borreliae could be grouped into three subtypes
according to variations at seven amino acid positions. The
results for 14 strains are given in Table 2. It would be very
interesting to complete these gene analyses for other regions
in the Middle East and to include other Eurasian pathogenic
species.
Microbiological Diagnosis
With standard microscopy, B. persica appears very similar to
other TBRF borreliae (Fig. 5). Using dark-ﬁeld microscopy of
blood from human clinical cases and mice inoculated with
Borrelia-positive human blood, we have observed that B. persi-
ca isolates have the tendency to adhere to one red blood
cell. Borreliae can survive for 1 or 2 days at room tempera-
ture, but when kept at 4C, they rapidly lose motility, and
animal inoculations become unsuccessful.
Thin and thick blood smears are most frequently used
for laboratory diagnosis. In our experience, the sensitivity
of the microscopic methods averages 80%. The morphology
of Borrelia is better conserved in thin blood smears
(Fig. 5a,b), but thick blood smears (Fig. 5c,d) can improve
the sensitivity. Dark-ﬁeld microscopy of fresh blood sam-
ples (Fig. 6) can also improve the sensitivity, as the motility
of Borrelia can help in the detection of discrete bactera-
emia.
A list of experimental animals is given in Table 1. We have
succeeded in inoculating B. persica into mice (ICR, Harlan,
Israel) via the intraperitoneal route with 200 lL of blood
from human cases and positive mouse blood samples.
Attempts at in vitro cultivation in BSK-H complete medium
(B8291, Sigma-Aldrich, Rehovot, Israel) and BSK-H (B3528,
Sigma-Aldrich, Rehovot, Israel) supplemented with rabbit
 HumanBloodHB4
 HumanBloodHB2
OtholozaniTG5250
81 Type II
 HumanBloodHB3
 OtholozaniCBkc7
 OtholozaniTGd1
100
66
5275
Type I
HumanBloodC1015B
 HumanBloodFL1
 HumanBloodHB1
 AY934619Bparkeri99
35
Type III
 AY934623Bparkeri
 D82862Bturicatae
 AY597787Bhermsii
AY597791Bhermsii
100
100
100
 AY597795Bhermsii
 AY597798Bhermsii
 DQ346832Bduttonii
95
100
 D82859Bduttonii
 X75204Bcrocidurae
 BCU28496Bcrocidurae
 DQ346833Bduttonii
68
60
78
100
 D86618Brecurrentis63
0.01
FIG. 4. Phylogenetic tree based on ﬂaB nucle-
otide sequences. The tree was constructed
using the neighbour-joining method with a
pairwise deletion procedure. Distances were
calculated according to Jukes and Cantor.
Numbers at nodes correspond to the percent-
age conﬁdence level in a bootstrap test
performed on 1000 replicates. The scale bar
corresponds to a distance of 0.01. The
GenBank accession numbers for nucleotide
sequences of Borrelia persica ﬂaB shown here
are as follows: Human Blood FL1, DQ673617;
Human Blood C1015B, DQ679904; Ornithodo-
ros tholozani CBkc7, DQ679905; Human
Blood 1, DQ679906; Human Blood 2,
DQ679907; Human Blood 3, DQ679908;
Human Blood 4, DQ679909; O. tholozani
TG52, DQ679910; and O. tholozani TGd1,
DQ679911.
TABLE 2. Amino-acid variations in, and type deﬁnition of
the ﬂagellin FlaB in 14 samples of TBRF-causing Borreliae
persica
Type
Amino Acid Position*
Number
of strains86 105 134 195 216 217 228 231
Type I V A R A - A I I 7
Type II V A R S A A I I 6
Type III I S H A - A T V 1
*: Numbering according the amino acid sequence of FlaB of Borrelia. hermsii
(GenBank accession: gi|1311448|)
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serum were unsuccessful. One explanation could be that
bacteraemia did not exceed ﬁve to ten organisms per 10 lL.
Molecular analysis is the most sensitive diagnostic method,
and has the advantage of allowing species identiﬁcation by
sequencing [13,15] or on the basis of restriction patterns
[33]. This type of analysis can also be performed on frozen
blood or samples kept for several days at 4C, and three
sequences of genes (ﬂaB [15], glpQ and 16S rRNA genes
[13]) have been successfully used for PCR.
To our knowledge, speciﬁc serology for B. persica is not
available. Some authors have reported the usefulness of
Lyme borreliosis ELISA serology, taking advantage of the
interspecies cross-reactions with sensitivities of 50% [35]
and 89% [14]. Serological GlpQ assays have been used for
RF [36]. However, serological methods could not
differentiate between active and past disease.
Treatment and Prevention
Treatment of TBRF caused by B. persica does not differ
from that of TBRF caused by other borreliae, and is based
on doxycycline [10,17]. A high frequency of Jarisch–Herx-
heimer reactions, approximately 80%, has been reported
[14].
Public education concerning the risks involved in entering
caves, combined with prevention measures in countries in
(a)
(c)
(b)
(d)
FIG. 5. Thin (a, b) and thick (c, d) blood smears showing Borrelia persica (·1000, Giemsa stain).
FIG. 6. Borrelia persica in patient’s blood under dark-ﬁeld examina-
tion.
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which O. tholozani lives primarily in caves and similar sites, is
effective in reducing the number of TBRF cases. Persons
entering caves must wear appropriate shoes and clothes cov-
ering all the body. It is recommended to spray shoes and the
trouser bottoms with a repellant. Avoidance of long stays in
caves reduces the opportunities for ticks to identify the host.
Sleeping in caves or at nearby sites must be avoided. If it is
necessary to stay in caves or at archaeological or similar sites
for an extended period, it is necessary to monitor whether
the place is infested with ticks, and to spray the site with
suitable residual insecticides. It is recommended to spray the
ground until it is wet and the walls of the cave up to a height
of 1 m. If prolonged work is necessary, the work should be
stopped for several days for respraying.
For single exposures, the classic pre-exposure prophylaxis
based on doxycycline is used; it can be similarly used for
post-exposure prevention [14]. In this study, no
Jarisch–Herxheimer reactions occurred with pre-exposure
or post-exposure use of doxycycline. However, this drug has
many side effects. For this reason, we used amoxycillin in
our ﬁeld studies for pre-exposure and post-exposure treat-
ment, and this proved to be successful.
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